Form 4: OPKO HEALTH, INC. Sells Shares of GeneDx Holdings Corp.
SEC Form 4
OPKO HEALTH, INC. reports the sale of 88,839 shares of GeneDx Holdings Corp. Class A Common Stock at an average price of $33.5027 on July 31, 2024.
Summary
- On July 31, 2024, OPKO HEALTH, INC. sold 88,839 shares of GeneDx Holdings Corp. Class A Common Stock.
- The shares were sold at a weighted average price of $33.5027.
- The prices for individual transactions ranged from $33.00 to $34.21.
- Following the transaction, OPKO HEALTH, INC. beneficially owns 2,984,564 shares of GeneDx Holdings Corp.
- The sale was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of share sales. The impact depends on the reasons behind the sale and the market's perception.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and major shareholders, providing transparency to the market.
Stakeholder Impact
- Shareholders may react to the news of OPKO HEALTH, INC.'s share sale, potentially affecting the stock price of GeneDx Holdings Corp.
Key Dates
| Date | Description |
|---|---|
| 07/31/2024 | Date of the transaction: OPKO HEALTH, INC. sold shares of GeneDx Holdings Corp. |
| 08/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.